Cargando…

The efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers

OBJECTIVES: The present study aims to evaluate the healing effect of a new topical paste formulation on mucosal wounds. METHODS: This study was conducted in 40 adult male rabbits. The animals were divided into two groups: a control group containing rabbits that were treated with only Orabase paste (...

Descripción completa

Detalles Bibliográficos
Autores principales: Abid, Wafaa K., Naser, Alyaa I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taibah University 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498728/
https://www.ncbi.nlm.nih.gov/pubmed/34690654
http://dx.doi.org/10.1016/j.jtumed.2021.05.005
_version_ 1784580229585436672
author Abid, Wafaa K.
Naser, Alyaa I.
author_facet Abid, Wafaa K.
Naser, Alyaa I.
author_sort Abid, Wafaa K.
collection PubMed
description OBJECTIVES: The present study aims to evaluate the healing effect of a new topical paste formulation on mucosal wounds. METHODS: This study was conducted in 40 adult male rabbits. The animals were divided into two groups: a control group containing rabbits that were treated with only Orabase paste (comprising olive oil and beeswax) and an experimental group that included rabbits that were treated with Orabase paste containing hyaluronic acid, rosemary extract, and metronidazole. Each of these groups was randomly divided into four groups according to the observational period (post-treatment days 1, 3, 7, and 15). Further, biopsy samples for histological examination were obtained from the animals’ oral mucosal defects. RESULTS: We found that the new formulation (Orabase paste containing hyaluronic acid, rosemary extract, and metronidazole) had a stronger healing effect. The inflammation and re-epithelization scores at 3–7 days for the experimental group appeared superior in which (P-values were 0.038 and 0.034 for inflammation and 0.046 and 0.025 for re-epithelization) respectively. Furthermore, the re-epithelization score on the 15th day for the new formulation was significant (P ≤ 0.05), with the inflammatory response being milder. CONCLUSIONS: Topical application of new paste formulation provided good therapeutic results. The new formulation was effective in resolving inflammation during specific phases of mucosal healing and significantly advanced wound healing at different stages. It also afforded a better healing response in terms of reduced wound contraction.
format Online
Article
Text
id pubmed-8498728
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taibah University
record_format MEDLINE/PubMed
spelling pubmed-84987282021-10-21 The efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers Abid, Wafaa K. Naser, Alyaa I. J Taibah Univ Med Sci Original Article OBJECTIVES: The present study aims to evaluate the healing effect of a new topical paste formulation on mucosal wounds. METHODS: This study was conducted in 40 adult male rabbits. The animals were divided into two groups: a control group containing rabbits that were treated with only Orabase paste (comprising olive oil and beeswax) and an experimental group that included rabbits that were treated with Orabase paste containing hyaluronic acid, rosemary extract, and metronidazole. Each of these groups was randomly divided into four groups according to the observational period (post-treatment days 1, 3, 7, and 15). Further, biopsy samples for histological examination were obtained from the animals’ oral mucosal defects. RESULTS: We found that the new formulation (Orabase paste containing hyaluronic acid, rosemary extract, and metronidazole) had a stronger healing effect. The inflammation and re-epithelization scores at 3–7 days for the experimental group appeared superior in which (P-values were 0.038 and 0.034 for inflammation and 0.046 and 0.025 for re-epithelization) respectively. Furthermore, the re-epithelization score on the 15th day for the new formulation was significant (P ≤ 0.05), with the inflammatory response being milder. CONCLUSIONS: Topical application of new paste formulation provided good therapeutic results. The new formulation was effective in resolving inflammation during specific phases of mucosal healing and significantly advanced wound healing at different stages. It also afforded a better healing response in terms of reduced wound contraction. Taibah University 2021-06-12 /pmc/articles/PMC8498728/ /pubmed/34690654 http://dx.doi.org/10.1016/j.jtumed.2021.05.005 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Abid, Wafaa K.
Naser, Alyaa I.
The efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers
title The efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers
title_full The efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers
title_fullStr The efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers
title_full_unstemmed The efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers
title_short The efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers
title_sort efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498728/
https://www.ncbi.nlm.nih.gov/pubmed/34690654
http://dx.doi.org/10.1016/j.jtumed.2021.05.005
work_keys_str_mv AT abidwafaak theefficacyofanewpasteformulationasanalternativetherapeuticagentfortraumaticulcers
AT naseralyaai theefficacyofanewpasteformulationasanalternativetherapeuticagentfortraumaticulcers
AT abidwafaak efficacyofanewpasteformulationasanalternativetherapeuticagentfortraumaticulcers
AT naseralyaai efficacyofanewpasteformulationasanalternativetherapeuticagentfortraumaticulcers